Cargando…
Proteomic Characterization of Plasma Rich in Growth Factors and Undiluted Autologous Serum
Over the last three decades, there has been special interest in developing drugs that mimic the characteristics of natural tears for use it in the treatment of several ocular surface disorders. Interestingly, the composition of blood plasma is very similar to tears. Therefore, different blood-derive...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618701/ https://www.ncbi.nlm.nih.gov/pubmed/34830053 http://dx.doi.org/10.3390/ijms222212176 |
_version_ | 1784604811365187584 |
---|---|
author | Anitua, Eduardo Muruzabal, Francisco Pino, Ander Prado, Roberto Azkargorta, Mikel Elortza, Felix Merayo-Lloves, Jesús |
author_facet | Anitua, Eduardo Muruzabal, Francisco Pino, Ander Prado, Roberto Azkargorta, Mikel Elortza, Felix Merayo-Lloves, Jesús |
author_sort | Anitua, Eduardo |
collection | PubMed |
description | Over the last three decades, there has been special interest in developing drugs that mimic the characteristics of natural tears for use it in the treatment of several ocular surface disorders. Interestingly, the composition of blood plasma is very similar to tears. Therefore, different blood-derived products like autologous serum (AS) and plasma rich in growth factors (PRGF) have been developed for the treatment of diverse ocular pathologies. However, scarce studies have been carried out to analyze the differences between both types of blood-derived products. In the present study, blood from three healthy donors was drawn and processed to obtain AS and PRGF eye drops. Then, human corneal stromal keratocytes (HK) were treated with PRGF or undiluted AS. Proteomic analysis was carried out to analyze and characterize the differential protein profiles between PRGF and AS, and the differentially expressed proteins in HK cells after PRGF and AS treatment. The results obtained in the present study show that undiluted AS induces the activation of different pathways related to an inflammatory, angiogenic, oxidative stress and scarring response in HK cells regarding PRGF. These results suggest that PRGF could be a better alternative than AS for the treatment of ocular surface disorders. |
format | Online Article Text |
id | pubmed-8618701 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-86187012021-11-27 Proteomic Characterization of Plasma Rich in Growth Factors and Undiluted Autologous Serum Anitua, Eduardo Muruzabal, Francisco Pino, Ander Prado, Roberto Azkargorta, Mikel Elortza, Felix Merayo-Lloves, Jesús Int J Mol Sci Article Over the last three decades, there has been special interest in developing drugs that mimic the characteristics of natural tears for use it in the treatment of several ocular surface disorders. Interestingly, the composition of blood plasma is very similar to tears. Therefore, different blood-derived products like autologous serum (AS) and plasma rich in growth factors (PRGF) have been developed for the treatment of diverse ocular pathologies. However, scarce studies have been carried out to analyze the differences between both types of blood-derived products. In the present study, blood from three healthy donors was drawn and processed to obtain AS and PRGF eye drops. Then, human corneal stromal keratocytes (HK) were treated with PRGF or undiluted AS. Proteomic analysis was carried out to analyze and characterize the differential protein profiles between PRGF and AS, and the differentially expressed proteins in HK cells after PRGF and AS treatment. The results obtained in the present study show that undiluted AS induces the activation of different pathways related to an inflammatory, angiogenic, oxidative stress and scarring response in HK cells regarding PRGF. These results suggest that PRGF could be a better alternative than AS for the treatment of ocular surface disorders. MDPI 2021-11-10 /pmc/articles/PMC8618701/ /pubmed/34830053 http://dx.doi.org/10.3390/ijms222212176 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Anitua, Eduardo Muruzabal, Francisco Pino, Ander Prado, Roberto Azkargorta, Mikel Elortza, Felix Merayo-Lloves, Jesús Proteomic Characterization of Plasma Rich in Growth Factors and Undiluted Autologous Serum |
title | Proteomic Characterization of Plasma Rich in Growth Factors and Undiluted Autologous Serum |
title_full | Proteomic Characterization of Plasma Rich in Growth Factors and Undiluted Autologous Serum |
title_fullStr | Proteomic Characterization of Plasma Rich in Growth Factors and Undiluted Autologous Serum |
title_full_unstemmed | Proteomic Characterization of Plasma Rich in Growth Factors and Undiluted Autologous Serum |
title_short | Proteomic Characterization of Plasma Rich in Growth Factors and Undiluted Autologous Serum |
title_sort | proteomic characterization of plasma rich in growth factors and undiluted autologous serum |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618701/ https://www.ncbi.nlm.nih.gov/pubmed/34830053 http://dx.doi.org/10.3390/ijms222212176 |
work_keys_str_mv | AT anituaeduardo proteomiccharacterizationofplasmarichingrowthfactorsandundilutedautologousserum AT muruzabalfrancisco proteomiccharacterizationofplasmarichingrowthfactorsandundilutedautologousserum AT pinoander proteomiccharacterizationofplasmarichingrowthfactorsandundilutedautologousserum AT pradoroberto proteomiccharacterizationofplasmarichingrowthfactorsandundilutedautologousserum AT azkargortamikel proteomiccharacterizationofplasmarichingrowthfactorsandundilutedautologousserum AT elortzafelix proteomiccharacterizationofplasmarichingrowthfactorsandundilutedautologousserum AT merayollovesjesus proteomiccharacterizationofplasmarichingrowthfactorsandundilutedautologousserum |